Abingdon Health Plc
ABDXF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $3,871 | $3,725 | $1,205 | $2,934 |
| % Growth | 3.9% | 209.1% | -58.9% | – |
| Cost of Goods Sold | $1,910 | $1,324 | $1,417 | $1,490 |
| Gross Profit | $1,184 | $2,401 | -$212 | $1,444 |
| % Margin | 30.6% | 64.5% | -17.6% | 49.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,210 | $2,342 | $1,364 | $1,329 |
| SG&A Expenses | $3,276 | $2,380 | $2,738 | $2,678 |
| Sales & Mktg Exp. | $66 | $38 | $1,374 | $1,350 |
| Other Operating Expenses | $549 | $182 | $0 | $0 |
| Operating Expenses | $3,825 | $2,562 | $2,738 | $2,678 |
| Operating Income | -$2,641 | -$161 | -$1,745 | -$1,234 |
| % Margin | -68.2% | -4.3% | -144.8% | -42.1% |
| Other Income/Exp. Net | $8 | -$18 | $1,135 | $659 |
| Pre-Tax Income | -$2,633 | -$179 | -$610 | -$1,150 |
| Tax Expense | -$140 | -$113 | -$15 | -$120 |
| Net Income | -$3,154 | -$66 | -$1,205 | -$1,030 |
| % Margin | -81.5% | -1.8% | -100% | -35.1% |
| EPS | -0.007 | -0 | -0.002 | -0.003 |
| % Growth | -3,450% | 90% | 41.2% | – |
| EPS Diluted | -0.007 | -0 | -0.002 | -0.003 |
| Weighted Avg Shares Out | 354,671 | 305,556 | 301,250 | 304,034 |
| Weighted Avg Shares Out Dil | 354,640 | 305,441 | 304,034 | 304,034 |
| Supplemental Information | – | – | – | – |
| Interest Income | $60 | $0 | $26 | $57 |
| Interest Expense | $50 | $18 | $34 | $41 |
| Depreciation & Amortization | $267 | $141 | $285 | $343 |
| EBITDA | -$1,964 | -$1 | -$447 | -$188 |
| % Margin | -50.7% | -0% | -37.1% | -6.4% |